| 摘要 |
<p>Compounds having the formula I wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, Rdand n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.</p> |
